In a recent cancer vaccine study, an increased salt concentration in the vaccine formulation dramatically improved vaccination-induced tumor rejection through CD8+ T cells in a mouse E.G7-OVA lymphoma model (Luo et al., 2017). Here, CD8A is linked to neoplasm.